| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ADAPY (ADAPY) has 4 insiders with recent SEC Form 4 filings, including 11 buys and 4 sells. ADAPY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 100.37M | $3.41M | - | |
| COO | 986.4K | $33.5K | - | |
| CFO | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2019 | Bertrand William C Jr | Chief Operating Officer | Sell | 2,271 | $5.37 | $12,193.91 | -37.8% | |
| Jan 14, 2019 | Amado Rafael65 | President, R &D | Sell | 3,028 | $5.37 | $16,258.54 | -37.8% | |
| Jan 14, 2019 | Rawcliffe Adrian | Chief Financial Officer | Sell | 3,084 | $5.37 | $16,559.23 | -48.2% | |
| Dec 17, 2018 | Alleva Lawrence M | Director | Buy | 47,280 | $0.84 | $39,715.20 | New | |
| Oct 1, 2018 | Binder-Scholl Gwendolyn Knowlton | Chief Technology Officer | Sell | 25,000 | $13.79 | $344,750.00 | -100% | |
| Sep 7, 2018 | Florence Anthony A. Jr.56 | 10% Owner | Buy | 15,000,000 | $1.67 | $25,000,500.00 | +18.8% | |
| Sep 7, 2018 | Viswanathan Ravi | 10% Owner | Buy | 15,000,000 | $1.67 | $25,000,500.00 | +18.8% | |
| Sep 7, 2018 | Sonsini Peter W. | 10% Owner | Buy | 15,000,000 | $1.67 | $25,000,500.00 | +18.8% | |
| Sep 7, 2018 | Barris Peter J | 10% Owner | Buy | 15,000,000 | $1.67 | $25,000,500.00 | +18.8% | |
| Sep 7, 2018 | Sandell Scott D55 | 10% Owner | Buy | 15,000,000 | $1.67 | $25,000,500.00 | +18.8% |